Success Metrics

Active Trials
1(20%)

Phase Distribution

Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Other(3)

Detailed Status

unknown3
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown360%
recruiting120%
not_yet_recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
not_yet_recruiting

Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population

NCT06366308
unknown

Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV

NCT04251546
recruitingnot_applicable

Focal Therapy for Prostate Cancer Using HIFU

NCT01194648
unknownnot_applicable

Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections

NCT03496142
unknownnot_applicable

MRI in Diagnosing Prostate Cancer

NCT01292291

Clinical Trials (5)

Showing 5 of 5 trials
NCT06366308

Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population

Not Yet Recruiting
NCT04251546

Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV

Unknown
NCT01194648Not Applicable

Focal Therapy for Prostate Cancer Using HIFU

Recruiting
NCT03496142Not Applicable

Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections

Unknown
NCT01292291Not Applicable

MRI in Diagnosing Prostate Cancer

Unknown

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5